Pharma Prescribed with Wessam Sonbol, CEO of Delve Health; From personal struggle to future global impact

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? At the helm of Delve Health, Wessam Sonbol is driving a revolution in decentralized and hybrid clinical trials. His platform supports studies in over 65 languages, enabling inclusive research across continents. By integrating wearables, TeleVisits, and AI-driven tools, Delve Health has helped sponsors reduce patient dropout rates by up to 30% and accelerate trial timelines by 20%. Wessam’s leadership spans more than 25 years in clinical research and healthcare technology. He’s managed complex Phase I–IV and 510(k) trials for global giants like Medtronic, Abbott Vascular, and Johnson & Johnson. His entrepreneurial journey includes founding Clinical Systems Consultants—scaling it across three continents—and developing platforms that achieved multi-million dollar exits. Inspired by personal experience, Wessam is fiercely committed to patient-centricity. His innovations simplify trial access and elevate outcomes. He also co-developed Perta.io, a data mining platform that connects clinical trials, publications, and drug pipelines using AI and NLP—cutting research time by up to 40% for scientists and sponsors. Whether it’s through founding companies or building ecosystems, Wessam doesn’t just follow the pulse of clinical research. He shapes it.

There are no comments yet.

Please log in to write the first comment.